Controversies in the management of clinical stage i testicular seminoma

B. Gliński , A. Mucha-Małecka , Anna Chrostowska (1) , K. Małecki , P. Hebzda , D. Wojton

1 IPREM - Institut des sciences analytiques et de physico-chimie pour l'environnement et les materiaux

Stage I seminoma is the most frequently occurring single stage/histology of testicular cancer, comprising up to 80% of seminomas. Seminomas comprise about 40% of all testicular cancers. Its management is controversial, several treatment options after orchiectomy are considered. These are surveillance, radiation alone or chemotherapy alone. Active surveillance (with treatment upon relapse), adjuvant irradiation, and adjuvant carboplatin, each achieve an overall survival approaching 100%. In this article, we review the existing literature and recent recommendations for the various treatment options, and their advantages and disadvantages.

Mots clés: Chemotherapy; Radiotherapy; Seminoma; Surveillance

Domaines: Chimie inorganique; Chimie organique

B. Gliński, A. Mucha-Małecka, Anna Chrostowska, K. Małecki, P. Hebzda, et al.. Controversies in the management of clinical stage i testicular seminoma. Nowotwory, 2012, 62 (3), pp.188--192. ⟨hal-01566329⟩